Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
6.91%
Grew
—
—
Shrank
—
1 Year
Score—
Net Growth6.91%
Net TrendGrew
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
1.8
-214.71%
40%
—
-100.00%
Never
—
5 Years
Score1.8
Net Growth-214.71%
Net Trend40%
Net Income Consistency—
Rev Growth-100.00%
Rev TrendNever
Revenue Consistency—
Cullinan Oncology LLC fundamental performance
Between 2021 and 2025, revenue declined from $ 18M to $ 0.00 and net income went from -$ 65M to -$ 219M. Revenue increased in 0% of the years measured; net income in 40%.
Cullinan Oncology LLC currently holds a 5-year HDB Score of 1.8 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 19.60 | — |
1 Year2025-08-12 | $ 7.27 | 169.60% |
5 Years2021-08-12 | $ 28.43 | -31.06% |
All Time2021-01-08 | $ 29.91 | -34.47% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2021-01-08 |
|---|---|---|---|---|
| Price | $ 19.60 | $ 7.27 | $ 28.43 | $ 29.91 |
| Return | — | 169.60% | -31.06% | -34.47% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 204M | $ 334M |
| 2025 | $ 0.00 | -$ 219M | $ 377M |
| 2024 | $ 0.00 | -$ 167M | $ 398M |
| 2023 | $ 0.00 | -$ 153M | $ 467M |
| 2022 | $ 0.00 | $ 111M | $ 467M |
| IPO2021 | $ 18M | -$ 65M | $ 290M |
Explore beyond CGEM
You're looking at Cullinan Oncology LLC. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
